Zobrazeno 1 - 10 of 88 pro vyhledávání: '"Joost Bart"'
1
Akademický článek
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study
Autor: Anneke L. Eerkens, Koen Brummel, Annegé Vledder, Sterre T. Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M. de Lange, Rie Klomp, David Church, Arja ter Elst, René Wardenaar, Diana Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K. L. Reyners, Marco de Bruyn, Hans W. Nijman
Publikováno v: Nature Communications, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Neoadjuvant immune checkpoint blockade (ICB) has shown unprecedented activity in mismatch repair deficient (MMRd) colorectal cancers, but its effectiveness in MMRd endometrial cancer (EC) remains unknown. In this investigator-driven, phase I
Externí odkaz: https://doaj.org/article/1b7aedf643dd44ed914769ada0de8d61
Zobrazit plný text záznamu
2
Akademický článek
Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
Autor: Marissa C. van Maaren, Agustín Ortega Ávila, Jeannette G. van Manen, Marian BE. Menke-Pluijmers, Jeroen Veltman, Joost Bart, Pieter J. Westenend, Sabine Siesling
Publikováno v: Breast, Vol 59, Iss , Pp 376-382 (2021)
Purpose: We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the Netherlands. Methods: All women diagnosed with classic LCIS between 1989
Externí odkaz: https://doaj.org/article/525cbb0680f24c4cb205fada0329fb19
Zobrazit plný text záznamu
3
Akademický článek
Borderline ovarian tumor frozen section diagnoses with features suspicious of invasive cancer: a retrospective study
Autor: Koen De Decker, Karina H. Jaroch, Joost Bart, Loes F. S. Kooreman, Roy F. P. M. Kruitwagen, Hans W. Nijman, Arnold-Jan Kruse
Publikováno v: Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-6 (2021)
Abstract Background A frozen section diagnosis of a borderline ovarian tumor with suspicious features of invasive carcinoma (“at least borderline” or synonymous descriptions) presents us with the dilemma of whether or not to perform a full ovaria
Externí odkaz: https://doaj.org/article/496d1d8948d34f6ca7a3bff2aa70ff1e
Zobrazit plný text záznamu
4
Akademický článek
Variability in grading of ductal carcinoma in situ among an international group of pathologists
Autor: Maartje vanSeijen, Katarzyna Jóźwiak, Sarah E Pinder, Allison Hall, Savitri Krishnamurthy, Jeremy SJ Thomas, Laura C Collins, Jonathan Bijron, Joost Bart, Danielle Cohen, Wen Ng, Ihssane Bouybayoune, Hilary Stobart, Jan Hudecek, Michael Schaapveld, Alastair Thompson, Esther H Lips, Jelle Wesseling, The Grand Challenge PRECISION consortium.
Publikováno v: The Journal of Pathology: Clinical Research, Vol 7, Iss 3, Pp 233-242 (2021)
Abstract The prognostic value of cytonuclear grade in ductal carcinoma in situ (DCIS) is debated, partly due to high interobserver variability and the use of multiple guidelines. The aim of this study was to evaluate interobserver agreement in gradin
Externí odkaz: https://doaj.org/article/018d235b3e01461b8b9e9bd581a263c5
Zobrazit plný text záznamu
5
Akademický článek
Borderline tumours of the ovary: Common practice in the Netherlands
Autor: Koen De Decker, Henk G. ter Brugge, Joost Bart, Roy F.P.M. Kruitwagen, Hans W. Nijman, Arnold-Jan Kruse
Publikováno v: Gynecologic Oncology Reports, Vol 27, Iss , Pp 25-30 (2019)
Objectives: Discordance between frozen section diagnosis and the definite histopathological diagnosis and the fact that the frozen section result is not always unambiguous, may contribute to differences in clinical practice regarding perioperative tr
Externí odkaz: https://doaj.org/article/c4c432d469fe4500b4aee0f650180074
Zobrazit plný text záznamu
6
Akademický článek
Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer
Autor: Arjan Kol, Joyce M. Lubbers, Anouk L.J. Terwindt, Hagma H. Workel, Annechien Plat, G. Bea A. Wisman, Joost Bart, Hans W. Nijman, Marco De Bruyn
Publikováno v: OncoImmunology, Vol 10, Iss 1 (2021)
Activation of STimulator of INterferon Genes (STING) is important for induction of anti-tumor immunity. A dysfunctional STING pathway is observed in multiple cancer types and associates with poor prognosis and inferior response to immunotherapy. Howe
Externí odkaz: https://doaj.org/article/f6ac9b82b76f4f8da7fd453704dca627
Zobrazit plný text záznamu
7
Akademický článek
Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.
Autor: Esther de Boer, Lucia M A Crane, Marleen van Oosten, Bert van der Vegt, Tineke van der Sluis, Paulien Kooijman, Philip S Low, Ate G J van der Zee, Henriette J G Arts, Gooitzen M van Dam, Joost Bart
Publikováno v: PLoS ONE, Vol 10, Iss 8, p e0135012 (2015)
Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (FR-α) has already been identified as a suitable target for cancer therapy and imaging. FR-α is present on ~40% of human cancers. FR-β is known to b
Externí odkaz: https://doaj.org/article/8ee93fb047004a198179bddc54e38405
Zobrazit plný text záznamu
8
Akademický článek
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
Autor: Petra van der Groep, Paul J van Diest, Yvonne H C M Smolders, Margreet G E M Ausems, Rob B van der Luijt, Fred H Menko, Joost Bart, Elisabeth G E de Vries, Elsken van der Wall
Publikováno v: PLoS ONE, Vol 8, Iss 2, p e56055 (2013)
Recent studies have revealed that BRCA1 and BRCA2 germline mutation-related breast cancers show frequent overexpression of hypoxia inducible factor-1α (HIF-1α), the key regulator of the hypoxia response. However, the question remained whether hypox
Externí odkaz: https://doaj.org/article/ca6ec25253ea49c0af71564ae5eb3ccd
Zobrazit plný text záznamu
9
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands-A nationwide study
Autor: Koen De Decker, Hans H. B. Wenzel, Joost Bart, Maaike A. van der Aa, Roy F. P. M. Kruitwagen, Hans W. Nijman, Arnold‐Jan Kruse
Publikováno v: Acta Obstetricia et Gynecologica Scandinavica, 102(3), 246-256. Wiley
Acta Obstetricia et Gynecologica Scandinavica. Wiley
INTRODUCTION: Serous ovarian carcinomas constitute the largest group of epithelial ovarian cancer (60%-75%) and are further classified into high- and low-grade serous carcinoma. Low-grade serous carcinoma (LGSC) is a relatively rare subtype (approxim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35426a3fc4169b6077a5500c59eb0508
https://doi.org/10.1111/aogs.14518
Zobrazit plný text záznamu
10
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
Autor: Vincent M.T. de Jong, Yuwei Wang, Natalie D. ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jóźwiak, Michael Hauptmann, Sten Cornelissen, Willem Vreuls, Efraim H. Rosenberg, Esther A. Koop, Zsuzsanna Varga, Carolien H.M. van Deurzen, Antien L. Mooyaart, Alicia Córdoba, Emma J. Groen, Joost Bart, Stefan M. Willems, Vasiliki Zolota, Jelle Wesseling, Anna Sapino, Ewa Chmielik, Ales Ryska, Annegien Broeks, Adri C. Voogd, Sherene Loi, Stefan Michiels, Gabe S. Sonke, Elsken van der Wall, Sabine Siesling, Paul J. van Diest, Marjanka K. Schmidt, Marleen Kok, Gwen M.H.E. Dackus, Roberto Salgado, Sabine C. Linn
Publikováno v: Journal of Clinical Oncology, 40(21), 2361-2374. American Society of Clinical Oncology
Journal of clinical oncology, 40(21), 2361-2374. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(21), 2361-+. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(21), 2361-2374. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(21), 2361-2375. AMER SOC CLINICAL ONCOLOGY
PURPOSE Triple-negative breast cancer (TNBC) is considered aggressive, and therefore, virtually all young patients with TNBC receive (neo)adjuvant chemotherapy. Increased stromal tumor-infiltrating lymphocytes (sTILs) have been associated with a favo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e35986b901d9a6f99467bf0b51a21bd2
https://research.rug.nl/en/publications/b0c5c264-d290-449b-a0cb-a952280661b0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje